BRIEF-Fibrocell Science receives allowance from U.S. FDA to initiate a phase I/II clinical trial of FCX-007 in adults

* Received allowance from u.s. Food and drug administration

(fda) to initiate a phase i/ii clinical trial of fcx-007 in

adults

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more